Allergan, Inc. (AGN) Reports In-Line Q4 EPS of $1.00; Guides Q1, FY12
AGN Hot Sheet
EPS Growth %: +11.7%Financial Fact:
Diluted (in dollars per share): 0.74
Today's EPS Names:
TARO, BRLI, TLB, More
Allergan, Inc. (NYSE: AGN) reported Q4 EPS of $1.00, in-line with the analyst estimate of $1.00. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.41 billion.
Sees Q1 2012 EPS of $0.84-$0.86, versus the consensus of $0.91. Sees Q1 2012 revenue of $1.34-$1.39 billion, versus the consensus of $1.37 billion.
Sees FY2012 revenue of $5.65-$5.85 billion, versus the consensus of $5.89 billion.
For earnings history and earnings-related data on Allergan, Inc. (AGN) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Sees Q1 2012 EPS of $0.84-$0.86, versus the consensus of $0.91. Sees Q1 2012 revenue of $1.34-$1.39 billion, versus the consensus of $1.37 billion.
Sees FY2012 revenue of $5.65-$5.85 billion, versus the consensus of $5.89 billion.
For earnings history and earnings-related data on Allergan, Inc. (AGN) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Patterson Companies, Inc. (PDCO) Tops Q4 EPS by 5c; Guides FY12
- Jiayuan.com (DATE) Reports In-Line Q1 EPS of 5c; Guides Q2 Revs
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
